Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MERCK & CO., INC.

(MRK)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Merck : Truist Assumes Merck & Company at Buy Rating With $92 Price Target

07/27/2021 | 12:52pm EDT


ę MT Newswires 2021
All news about MERCK & CO., INC.
09/21MERCK : Thinking about trading options or stock in Draftkings, Merck, ConocoPhillips, Walg..
PR
09/21MERCK : Building Sustainable Value for our Business and Society
PU
09/20MERCK : KEYTRUDA (pembrolizumab) Plus Chemotherapy With or Without Bevacizumab Reduced Ris..
AQ
09/20MERCK : KEYTRUDA (pembrolizumab) Plus Chemotherapy Reduced Risk of Death by 27% Versus Che..
AQ
09/20MERCK : Receives Positive EU CHMP Opinion for KEYTRUDA (pembrolizumab) in Combination With..
AQ
09/20MERCK : KEYTRUDA (pembrolizumab) Demonstrated Superior Recurrence-Free Survival (RFS) in P..
AQ
09/19MERCK : KEYTRUDA« (pembrolizumab) Plus Chemotherapy Reduced Risk of Death by 27% Versus Ch..
BU
09/18MERCK : KEYTRUDA« (pembrolizumab) Plus Chemotherapy With or Without Bevacizumab Reduced Ri..
BU
09/18MERCK : KEYTRUDA« (pembrolizumab) Demonstrated Superior Recurrence-Free Survival (RFS) in ..
BU
09/18Merck Announces the First Results from the Phase 3 Keynote-716 Trial
CI
More news
Analyst Recommendations on MERCK & CO., INC.
More recommendations
Financials (USD)
Sales 2021 46 881 M - -
Net income 2021 12 645 M - -
Net Debt 2021 15 254 M - -
P/E ratio 2021 15,7x
Yield 2021 3,60%
Capitalization 182 B 182 B -
EV / Sales 2021 4,21x
EV / Sales 2022 3,81x
Nbr of Employees 73 500
Free-Float 70,7%
Chart MERCK & CO., INC.
Duration : Period :
Merck & Co., Inc. Technical Analysis Chart | MRK | US58933Y1055 | MarketScreener
Technical analysis trends MERCK & CO., INC.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 22
Last Close Price 71,97 $
Average target price 93,42 $
Spread / Average Target 29,8%
EPS Revisions
Managers and Directors
Robert M. Davis President, Chief Executive Officer & Director
Caroline A. Litchfield Chief Financial Officer & Executive Vice President
Kenneth C. Frazier Executive Chairman
Sandy Tremps Vice President-R&D IT CIO
Dave Williams Chief Information & Digital Officer
Sector and Competitors
1st jan.Capi. (M$)
MERCK & CO., INC.-12.02%182 183
JOHNSON & JOHNSON4.54%433 122
ROCHE HOLDING AG9.82%321 584
PFIZER, INC.20.08%246 246
NOVO NORDISK A/S52.07%234 070
ELI LILLY AND COMPANY36.32%208 668